Loring Wolcott & Coolidge Fiduciary Advisors’s iShares iBonds Dec 2026 Term Corporate ETF IBDR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.5K Hold
2,000
﹤0.01% 439
2026
Q1
$48.4K Hold
2,000
﹤0.01% 428
2025
Q4
$48.6K Hold
2,000
﹤0.01% 419
2025
Q3
$48.6K Hold
2,000
﹤0.01% 429
2025
Q2
$48.5K Hold
2,000
﹤0.01% 389
2025
Q1
$48.3K Hold
2,000
﹤0.01% 383
2024
Q4
$48.3K Hold
2,000
﹤0.01% 393
2024
Q3
$48.3K Hold
2,000
﹤0.01% 387
2024
Q2
$47.9K Hold
2,000
﹤0.01% 395
2024
Q1
$47.4K Hold
2,000
﹤0.01% 401
2023
Q4
$47.9K Buy
+2,000
New +$47K ﹤0.01% 406

Other funds holding IBDR

Loring Wolcott & Coolidge Fiduciary Advisors's IBDR Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors held its iShares iBonds Dec 2026 Term Corporate ETF (IBDR) position steady in Q2 2026 at 2,000 shares worth $48.5K. The position accounts for ﹤0.01% of the portfolio, ranked #439.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in IBDR in Q4 2023 and has held it in 11 quarters since. The position peaked at $48.6K in Q3 2025. 194 funds tracked by Wall St. Rank hold IBDR as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 2,000 shares of iShares iBonds Dec 2026 Term Corporate ETF worth $48.5K as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors left its iShares iBonds Dec 2026 Term Corporate ETF share count unchanged in Q2 2026.
  • iShares iBonds Dec 2026 Term Corporate ETF made up ﹤0.01% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #439 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in iShares iBonds Dec 2026 Term Corporate ETF in Q4 2023 and has held it in 11 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's iShares iBonds Dec 2026 Term Corporate ETF position peaked at $48.6K in Q3 2025.
  • 194 funds tracked by Wall St. Rank held iShares iBonds Dec 2026 Term Corporate ETF as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.